Acuta Capital Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-104,800
| Closed | -$7.32M | – | 51 |
|
|
2022
Q3 | $7.32M | Buy |
104,800
+10,300
| +11% | +$719K | 3.15% | 12 |
|
|
2022
Q2 | $6.34M | Buy |
94,500
+42,000
| +80% | +$2.82M | 3.53% | 10 |
|
|
2022
Q1 | $4.32M | Buy |
52,500
+32,500
| +163% | +$2.67M | 2.02% | 17 |
|
|
2021
Q4 | $2.93M | Buy |
+20,000
| New | +$2.93M | 1.23% | 28 |
|
|
2021
Q2 | – | Sell |
-9,000
| Closed | -$1.54M | – | 49 |
|
|
2021
Q1 | $1.54M | Buy |
+9,000
| New | +$1.54M | 0.56% | 38 |
|
|
2019
Q4 | – | Sell |
-17,000
| Closed | -$1.32M | – | 48 |
|
|
2019
Q3 | $1.32M | Sell |
17,000
-45,500
| -73% | -$3.54M | 0.96% | 20 |
|
|
2019
Q2 | $6.44M | Buy |
62,500
+21,500
| +52% | +$2.21M | 2.29% | 16 |
|
|
2019
Q1 | $3.01M | Buy |
+41,000
| New | +$3.01M | 1.43% | 24 |
|
|
2018
Q2 | – | Sell |
-100,000
| Closed | -$3.07M | – | 64 |
|
|
2018
Q1 | $3.07M | Sell |
100,000
-55,000
| -35% | -$1.69M | 0.5% | 19 |
|
|
2017
Q4 | $2.83M | Buy |
+155,000
| New | +$2.83M | 0.53% | 21 |
|
|
2016
Q4 | – | Sell |
-125,000
| Closed | -$826K | – | 57 |
|
|
2016
Q3 | $826K | Hold |
125,000
| – | – | 0.31% | 42 |
|
|
2016
Q2 | $683K | Buy |
125,000
+21,717
| +21% | +$119K | 0.33% | 46 |
|
|
2016
Q1 | $2.21M | Buy |
103,283
+14,844
| +17% | +$318K | 1.24% | 23 |
|
|
2015
Q4 | $2.8M | Buy |
+88,439
| New | +$2.8M | 1.34% | 19 |
|